Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/2003
10/09/2003US20030190723 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190722 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190721 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190720 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190719 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190718 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190717 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190716 Used to produce pharmaceuticals, diagnostics, biosensors, bioreactors; PRO polypeptides
10/09/2003US20030190707 17 human secreted proteins
10/09/2003US20030190699 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190698 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190687 Interacts with human DR5 to produce agonistic or antagonistic effects including inhibition of cell proliferation and apoptosis; used to treat apoptosis-related disease and unregulated cell growth
10/09/2003US20030190680 Photocleavable bioreactive agents
10/09/2003US20030190669 Humanized antibody.
10/09/2003US20030190668 Identification and isolation of DNA and recombinant production of polypeptides
10/09/2003US20030190667 Identification and isolation of DNA and recombinant production of polypeptides
10/09/2003US20030190659 Oligomers that hybridize to Inhibition of Apoptosis (IAP) polynucleotides and methods for using them to enhance apoptosis and treat proliferative diseases
10/09/2003US20030190658 Diagnostics for the detection of Acidovorax avenae subsp. citrulli, causal agent of bacterial fruit blotch in melons
10/09/2003US20030190635 RNA interference mediated treatment of Alzheimer's disease using short interfering RNA
10/09/2003US20030190633 Support for fixing nucleotide and process for producing the same
10/09/2003US20030190632 By electronic control of the transport and attachment of specific binding entities to specific microlocations; concentrate analytes and reactants, remove non-specifically bound molecules, and improve detection of analytes
10/09/2003US20030190626 Having increased nuclease resistance and binding affinity to a complementary strand of nucleic acid; useful for modulating expression of a protein in organisms, for diagnosis, therapy of conditions responsive to oligonucleotide therapeutics
10/09/2003US20030190616 Differentially methylated sequences in pancreatic cancer
10/09/2003US20030190611 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190610 Proteins involved in differentiation, maintenance of multicellular organisms, e.g. proliferation, migration, interaction of cells through drugs
10/09/2003US20030190607 Polymorphisms in human pyruvate dehydrogenase E1 beta (PDH E1 beta) gene; for analysing allelic variation; bioinformatic applications
10/09/2003US20030190602 Cell-based detection and differentiation of disease states
10/09/2003CA2469720A1 Truncated lysostaphin molecule with enhanced staphylolytic activity
10/08/2003EP1350514A2 Therapeutic use of cis-element decoys in vivo
10/08/2003EP1350262A2 Cpg-like nucleic acids and methods of use thereof
10/08/2003EP1350106A2 Ultra-sensitive detection systems
10/08/2003EP1349940A2 55562 and 21617, novel human proteins and methods of use thereof
10/08/2003EP1349871A2 Novel marker for the diagnosis and therapy of tumours
10/08/2003EP1141137B1 Water-soluble rhodamine dyes and conjugates thereof
10/08/2003EP0906329B1 2'-substituted nucleosides and oligonucleotide derivatives
10/08/2003EP0882130B1 Human cancer antigen of tyrosinase-related protein 1 and gene encoding same
10/08/2003EP0750628B1 Fibroblast growth factor-10
10/08/2003EP0670898B1 Interleukin-3 (il-3) mutant polypeptides
10/08/2003CN1446915A Recombinant sweet protein suitable for expressed in filamentous fungus and its production methods
10/08/2003CN1123574C Ligands for FLT3 receptors
10/07/2003US6630585 Method for purifying nucleic acids from feces
10/07/2003US6630581 Condensing the 3'-OH or 5'-OH group of a support-bound nucleoside or oligonucleotide with a monomeric nucleoside phosphoramidite having a carbonate-protected hydroxyl group; treating the intermediate provided with a deprotecting reagent
10/07/2003US6630448 Isolated endostatin, especially approximately 20 kDa and corresponds to a C-terminal fragment of collagen type XVIII
10/07/2003US6630443 Detecting agonists and antagonists; treating under- and overexpression
10/07/2003US6630351 Transfecting a cell by attaching a reversible labile membrane activity inhibitor to a melittin peptide; adding peptide to solution containing the nucleic acid; endocytosis
10/07/2003US6630329 Generating a library of mutant nucleotide sequences; obtain nucleotide sequences, incubate with primers, amplification reaction mixture and inosine, amplify, recover mutant nucleotide sequences
10/07/2003US6630308 Generating preferential amino acid sequences on substrate; obtain substrate, deblock, expose to amino acids, recover preferential particles
10/07/2003CA2132540C A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses
10/07/2003CA1341443C Human c3b/c4b receptor (cr1) (the)
10/07/2003CA1341442C Transgenic animals
10/02/2003WO2003081202A2 Bioconjugate-nanoparticle probes
10/02/2003WO2003080835A1 Erbb3 based methods and compositions for treating neoplasms
10/02/2003WO2003080834A2 Purification methods for oligonucleotides and their analogs
10/02/2003WO2003080825A2 Further bmp-2 inducible kinases and the uses thereof
10/02/2003WO2003080646A2 Modified plasminogen activator inhibitor type-1 and methods based thereon
10/02/2003WO2003080638A2 Antisense iap nucleobase oligomers and uses thereof
10/02/2003WO2003079982A2 Gene amplification in cancer
10/02/2003WO2003079747A2 An isolated polynucleotide associated with type ii diabetes mellitus and methods of use thereof
10/02/2003WO2003064441A3 Oligonucleotides comprising alternating segments and uses thereof
10/02/2003WO2003062414A3 Methods of obtaining isoform specific expression in mammalian cells
10/02/2003WO2003054154A3 Antisense modulation of mucin 1, transmembrane expression
10/02/2003WO2003052143A3 New primers for the detection and identification of bacterial indicator groups and virulence factors
10/02/2003WO2003052133A3 Oligonucleotide analogues comprising intercalator pseudonucleotides
10/02/2003WO2003051910A3 Inhibitors of hepatitis c virus protease
10/02/2003WO2002059355A3 Polynucleotides for use as tags and tag complements, manufacture and use thereof
10/02/2003WO2002057289A8 Reagent for the isolation of rna
10/02/2003US20030187242 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187240 Nuclease resistant
10/02/2003US20030187239 Comprises nucleotide sequences coding membrane proteins for use as antiproliferative/antitumor/antiinflammatory agents; drug screening
10/02/2003US20030187238 Comprises nucleotide sequences coding membrane proteins for use as antiproliferative/antitumor/antiinflammatory agents; drug screening
10/02/2003US20030187230 Chimeric humanized monoclonal antibody for treating tumors and inflammation
10/02/2003US20030187229 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187228 Chimeric humanized monoclonal antibody for treating tumors and inflammation
10/02/2003US20030187218 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes by contacting blood with pro-polypeptides; cancer diagnosis
10/02/2003US20030187215 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes by contacting blood with pro-polypeptides; cancer diagnosis
10/02/2003US20030187214 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187212 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187206 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187197 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187196 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187195 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187194 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187193 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents
10/02/2003US20030187192 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents
10/02/2003US20030187191 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents
10/02/2003US20030187190 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents
10/02/2003US20030187189 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030186930 Uridine analogs and techniques for making and using
10/02/2003US20030186922 Therapeutic use of cis-element decoys in vivo
10/02/2003US20030186917 Method of treating edematous retinal disorders
10/02/2003US20030186912 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
10/02/2003US20030186911 Inhibition of infectious agents by exogenous oligonucleotides
10/02/2003US20030186909 Nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors
10/02/2003US20030186881 Nucleotide sequences comprising complementary DNA codes for cyclin-dependent kinases, that control phosphorylation in cells, used in diagnosis and prophylaxis of diseases
10/02/2003US20030186866 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
10/02/2003US20030186435 Comprises antagonist that inhibits activity or expression oxidoreductase (FABH) for treating bacterial infection; bactericides
10/02/2003US20030186427 Apparatus for selectively converting photogenerated reagent precursors to photogenerated reagents associated with parallel synthesis of molecular sequence arrays on solid surfaces
10/02/2003US20030186421 Comprises lipoprotein associated phospholipase A2 (Lp-PLA2) for diagnosing and treating atherosclerosis; enzyme inhibitors
10/02/2003US20030186408 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030186407 Comprises membrane protein for use as antitumor/antiproliferative/antiinflammatory/anticarcinogenic agents
1 ... 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 ... 899